InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,250.80
(
0.45%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.68
(
0.17%
)
Bitcoin
62,996.25
(
0.23%
)
Post# of 255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

stockguard

Send PM Follow Ignore
Followers 20
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

stockguard

Re: None

Wednesday, 06/09/2021 5:04:58 PM

Wednesday, June 09, 2021 5:04:58 PM

Post# of 255
AAV & Lentiviral Gene Therapies with Sio's Dr. Pavan Cheruvu Podcast

20_12_BPO_BusBiotech_Social_ep46
Fresh on the heels of a significant data readout on its AXO-AAV-GM1 candidate at the recent ASGCT meeting, Sio Gene Therapies CEO Pavan Cheruvu, M.D. joins the Business of Biotech podcast. We discuss Dr. Cheruvu's formative years and inspiration, his company's origins, its progress developing AAV and lentiviral gene therapies to treat GM1 gangliosidosis, Tay-Sachs / Sandhoff disease, and Parkinson's disease, and the challenges the company has overcome in a hybrid manufacturing environment that will ultimately transfer entirely in-house.

https://www.cellandgene.com/doc/aav-lentiviral-gene-therapies-with-sio-s-dr-pavan-cheruvu-0001?vm_tId=



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up